| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 0.9 |